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Abstract Xenograft transplantation is perhaps the most immunologically dif-
ficult problem in transplantation today. An overwhelming hyperacute rejec-
tion reaction (HAR) occurs within minutes of organ implantation. Preformed 
antibodies are thought to initiate this process. We used a pig-to-dog renal 
xenograft transplant model and investigated methods of decreasing the se-
verity of hyperacute rejection. Female pigs weighing 15-20 kg were used as 
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donors. Recipients were mongrel dogs weighing 15-25 kg. Experimental dogs 
were all given a number of treatments of /gG depletion using an antibody 
removal system (Dupont-Excorim). This machine immunoadsorbs plasma 
against a column containing immobilized staphylococcal protein A, which is 
known to hind the /gG Fe receptor. An 84% reduction in the /gG levels and a 
71% reduction in /gM levels was achieved. Postoperative assessment was 
made of urine output, time to onset of HAR, and histopathological examina-
tion of the rejected kidneys. Although cross-matches between donor lympho-
cytes and recipient sera remained strongly positive in the treated dogs, there 
was a two- to fourfold reduction in the titers. The time to onset of HAR was 
prolonged in the experimental group, and the urine output was increased 
slightly. The histopathologic changes in the experimental group generally 
showed signs of HAR, but of less intensity than in the nonimmunodepleted 
control group. 
Keywords: Immunoadsorption, xenotransplantation, immunodepletion, hyper-
acute rejection. 
Currently, one of the major limitations in renal transplantation involves the large 
number of sensitized dialysis patients. Blood transfusions, prior transplants, or 
multiple pregnancies can all play an etiologic role, but result in an identical situa-
tion. These highly sensitized patients, who have antibodies to most or all HLA 
antigens, are rendered immunologically untransplantable. At present there is no 
effective means of dealing with this problem, and these patients can spend years 
on transplant waiting lists.! 
Discordant xenograft transplantation, ie, organ transplantation across widely 
divergent species barriers, confronts the same type of barriers to transplantation 
seen in the sensitized patient. Preformed antibodies render the donor organ sus-
ceptible to a humorally mediated hyperacute rejection, which can occur within 
minutes. One of the most reliable and violent animal models of hyperacute rejec-
tion is evident in pig-to-dog renal xenotransplantation.2 Various experimental ap-
proaches have been attempted without success to obtain long-term survival of the 
xenografts. 
One potential solution to these problems utilizes the ability of the staphylo-
coccal protein A to bind selectively the Fc receptor of IgG3 and to sites on the 
Fab region of other immunoglobulin isotypes (eg, IgM)4 (Figs 1 and 2). A novel 
technology has been developed whereby plasma can be passed over a column of 
protein A-Sepharose, and the IgG and IgM, or any moiety containing an Fc 
receptor, can be adsorbed. 5 This technique of immunodepletion can decrease the 
level of preformed antibodies and thus should be potentially helpful in the abroga-
tion of the hyperacute rejection response. 
Materials and Methods 
Immunodepletion 
Male or female mongrel dogs weighing between 15 and 25 kg were anesthetized 
with pentothal, intubated, and maintained on a ventilator with 40% oxygen, keta-
mine 1.5 mg/kg every 1-2 h intravenously, and pancuronium 0.05-0.1 mg/kg 
every 1-2 h intravenously. Cutdowns in the neck on both the carotid artery and 
the external jugular vein were made and the vessels cannulated with 13-gauge 
Quinton-Scribner shunt cannulas. Arterial blood was fed into a Haemonetics 
V -50 plasmapheresis unit, which separates the red blood cells from the plasma. 
Citrate was used as an anticoagulant. The plasma was then fed into the immuno-
I 
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Figure 1. Schematic view of staphylococcal protein A binding to the Fc receptor of IgG 
and IgM. 
adsorption system which contains two columns of protein A attached to Sepha-
rose CL-4B (Immunosorba A) in parallel (Figs 3 and 4). The CITEM 10 (Excorim 
KG, Lund, Sweden/Dupont) is a computer-controlled device which controls the 
flow of plasma and various regeneration solutions over the two columns. While 
plasma was run across one column, the adsorbed IgG and IgM were eluted from 
the other column with low pH citrate. The immunodepleted plasma was then 
returned to the plasmapheresis unit, where it was added to the red cells and re-
turned to the dog via the venous cannula. Cycles of adsorption and elution were 
alternated in the column every 10 min during the treatment procedure under the 
control of the CITEM 10 monitor. Light absorbance and pH detectors were used 
to monitor and control blood flow and prevent excessive plasma loss or dilution. 
Alarms detected and warned of unsafe conditions in the treatment system, eg, air 
in the line, abnormal pressure changes, and low plasma pH. The alarms were 
programmed to stop the procedure if there was no operator response within one 
minute. At the end of the treatment procedure the CITEM 10 automatically re-
generated and preserved the two columns by filling them with a merthiolate pre-
servative solution. 
Continuous recording of pulse, blood pressure, and temperature was made, 
Protein A Immobil ized on 
Sepharose CL-4B 
Figure 2. Schematic view of Sepharose-bound protein A binding to antibody. 
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Figure 3. CITEM 10 (Excorim, Dupont), a computer-controlled device to remove IgG and 
IgM. 
and serial measurements of arterial blood gases, hematocrit, sodium, potassium, 
and ionized calcium were taken every 0.5 h. A variable number of plasma volume 
exchanges were performed, ranging from 5 vollday to 15 voll5 days, prior to the 
xenograft transplantation (see Table O. 
Recipients, Control Group 
With one exception (see below), control animals were treated identically with the 
experimental group, with the exception that they did not undergo pretransplant 
immunodepletion. 
Donors 
Female white outbred SPS pigs that weighed 15-20 kg were purchased from 
Shadyside Farms, Ohio, and served as donors. They were anesthetized with pen-
tothal and were maintained with 30% oxygen through an endotracheal tube. Con-
tinuous EKG monitoring was used. The donor pigs received intravenous Ringer's 
lactate (1000 mL) and furosemide (10 mg). After systemic heparinization (5000 
units) and in situ cooling with cold 4°C Ringer's lactate through an aortic cannula, 
the kidneys were removed en bloc. The kidneys were then separated, and one 
was transplanted heterotopically into the treated dog; the other kidney was trans-
planted into the paired control dog not treated with immunodepletion. 
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Surgical Technique 
The operative technique involved the exposure of the right common iliac artery 
and vein. The venous anastomosis was performed end-to-side with fine contin-
uous monofilament suture. The artery was then anastomosed end-to-end and the 
cross-clamps released. Total ischemia time was less than 2 h in every case. Warm 
ischemia time ranged from 30 to 45 min, with no more than 7 min difference 
between experimental and control animals. 
Measurements 
The time to onset of hyperacute rejection, urine output, and histopathology 
served as end points in the treated and control dogs. Time to onset of hyperacute 
rejection was calculated as the time until the first evidence of xenograft mottling. 
Urine output was calculated by placing a plastic catheter in the distal ureter and 
measuring the volume of urine every 15 min for the first 2 h after cross-clamp 
release. Histopathologic examination was performed on one section from each 
kidney after it was harvested at the end of the experiment. Sections were pro-
cessed routinely with light microscopy and evaluated for percent normal, con-
gested, and thrombosed glomeruli; tubular vacuolization or ATN; and interstitial 
hemorrhage, status of vessels, and overall impression. For immunofluorescence 
Figure 4. Immunodepletion. Blood from patient is separated into plasma and red cells: 
plasma is passed over Staph-A column in CITEM 10; immunodepleted plasma is returned 
with red cells to patient. 
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Dog 
Number 
1 
3 
4 
7 
9 
10 
12 
13 
14 
15 
17 
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Table 1 
A Summary of Protein A Depletion Studies Done on Canine 
Xenograft Recipients 
Plasma 
Number of Volume/ 
Treatments Treatment 
3 2.7 
2 3 
3 3 
5 2.8 
5 3 
5 
5 
5 
5 
5 
5 
Total 
Plasma 
Volume 
8 
6 
9 
14.2 
15 
.5 
5 
5 
5 
.5 
5 
None 
None 
None 
Additional 
Treatment 
None 
Cyclophosphamide/methylprednisolone 
iv 2-5 mg/kg . day . 
None 
PGE. 5 fLg/kg . min 
Cyclosporine 10 mg/kg . day 
+ azathioprine 2 mg/kg • day 
+ prednisone I mg/kg· day 
Cyclosporine 10 mg/kg . day 
+ azathioprine 2 mg/kg . day 
+ prednisone 1 mg/kg . day 
+ prostacyclin 0.4 fLg/kg . min 
(intraarterial) 
Cyclosporine 10 mg/kg . day 
+ azathioprine 2 mg/kg . day 
+ prednisone 1 mg/kg . day 
+ prostacyclin 0.4 fLg/kg . min 
(intraarterial) 
Cyclosporine 10 mg/kg . day 
+ azathioprine 2 mg/kg . day 
+ prednisone 1 mglkg . day 
+ synthetic prostacyclin iv 
studies, frozen sections from the harvested kidneys were stained using fluoresce-
inated goat anti-dog IgG (1/20) and IgM (1120) (Research Plus). Sections were 
evaluated for location and degree of positive immunostaining. Slides were read 
blindly. Cytoxic matching with titers was performed between recipient serum and 
donor lymphocytes pre- and postimmunoadsorption. IgG and IgM levels were 
assayed by an radial immunodiffusion technique using a commercially available 
kit (ICN Immunobiologicals). Plasma procoagulant activity was determined as 
the 1/500 dilution of the activated partial thromboplastin time. 
Additional Treatment (Table 1) 
In experiments 1, 3, 4, 7, and 10, no additional treatment was given beside im-
munodepletion. In experiment 9, the experimental animal only was given a 4-day 
course of intravenous cyclophosphamide 2-5 mg/kg . day and intravenous meth-
ylprednisolone 1-3 mg/kg . day. In experiment 22, both experimental and control 
recipients received PGE, 5 f.Lg/kg • h and the xenograft kidneys were flushed with 
500 f.Lg of PGE, on the back table. In experiments 13-17, both experimental and 
control dogs received cyclosporine 10 mg/kg . day, azathioprine 2 mg/kg' day, 
and prednisone 1 mg/kg . day, for 12 days (experiment 13), 10 days (experiments 
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14 and 15), and 21 days (experiment 17) preoperatively. In addition, in experi-
ments 14 and 15, both experimental and control dogs received intra arterial pros-
tacyclin 0.4 IJ..g/kg . min, immediately after xenotransplantation. In experiment 
17, both experimental and control dogs received synthetic prostacyclin intrave-
nously during and immediately after xenotransplantation. 
Results 
Eleven experiments were completed successfully. Six experiments could not be 
completed successfully. The causes of failure to complete a given experiment are 
listed in Table 2. In most of the cases, technical errors were responsible-cath-
eter placement problems, inadvertent disconnection from the ventilator, and 
overreplacement of potassium. In two cases, a picture of coagulopathy was seen. 
The latter two cases were done with the original venous cannulas system in which 
clotting of the cannulas was a recurring problem. 
IgG and IgM Immunodepletion 
Significant lowering of both serum IgG and IgM was achieved in all experimental 
animals treated with Staph-A immunodepletion (Figs 5-8). IgG levels were low-
ered by 84% from baseline and IgM levels were lowered 71% from baseline. In 
those experiments in which animals received immunodepletion treatment over 
more than one day, an overnight rebound was noted, presumably a reflection of 
reequilibration from the interstitium. Both IgG and IgM are known to be parti-
tioned between the intravascular and extravascular spaces. The CITEM to/anti-
body removal system was highly efficient in removing both the IgG and IgM in all 
cases. 
Experiment 
Number 
2 
5 
6 
8 
11 
16 
Table 2 
Causes of Failure to Complete Experiment 
Cause 
Experimental dog died during catheter placement (probable 
right ventricular perforation) 
Experimental dog died on 2d day of Staph-A 
depletion-coagulopathy, decreased platelets, hematocrit, 
BP 
Experimental dog died on 3d day of Staph-A 
depletion-coagulopathy, decreased platelets, ? DIC 
Experimental dog died during catheter placement after 
inadvertant disconnection from ventilator 
Control dog died during transplantation-hypotension, 
hypoxia 
Experimental dog died during Staph-A depletion-
hyperkalemia 
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Figure 5. IgG depletion in five dogs given mUltiple treatments of immunodepletion. 
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Figure 6. IgM depletion in five dogs given mUltiple treatments of immunodepletion. 
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Figure 7. IgO depletion in six dogs given one treatment of immunodepletion. 
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Figure 8. IgM depletion in six dogs given one treatment of immunodepletion. 
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Table 3 
Time to Hyperacute Rejection and Urine Output 
Parameter 
Time to HAR (min) 
Total urine output (mL) 
first hour 
second hour 
* p < .05. 
Time of Hyperacute Rejection (Table 3) 
Experimental 
37.9 ± 36.3 
35.9 ± 39.2 
26.9 ± 32.6 
9.0 ± 9.6 
Control 
10.6 ± 5.8* 
10.8 ± 8.3 
9.1 ± 8.0 
1.7 ± 2.6* 
The time to the onset of hyperacute rejection was prolonged in the experimental 
group, with a mean of 37.9 ± min as opposed to 10.6 ± min in the control group 
(p < .05), In two cases, the experimental kidney never appeared to have gross 
evidence of hyperacute rejection throughout the period of observation. 
Urine Output (Table 3) 
Animals in the experimental group tended to produce more urine than animals in 
the control group during the period of observation. This finding held during the 
first hour, second hour, and the total urine output, with a mean of 26.9,9.0, and 
35.9 mL in the experimental group and 9.1,1.7, and 10.8 mL in the control group, 
respectively. Because of variability, three differences only approached statistical 
significance (p < .11 at 1 h, p < .05 at 2 h, and p < .08 for 1 and 2 h combined). 
Cross-match 
Pre- and posttreatment cross-matches were performed using recipient serum and 
donor lymphocytes. Serial dilution of sera demonstrated positive cross-matches 
to 1/256-11512, prior to immunodepletion. Posttreatment cross-matches remained 
positive to dilutions of 1164-11128. Antibody levels declined, but not enough to 
abrogate HAR. 
Pathology 
There were no qualitative differences between the control and experimental 
groups in the appearance of the glomeruli and the tubules. The overall subjective 
impression was that there was a higher percentage of thrombosed glomeruli and 
thus a more severe degree of hyperacute rejection in the control animals, but 
statistically there was no significant difference. Positive immunostaining for IgG 
and IgM was in the mesangium in all kidneys. IgG was the same in experimental 
and control kidneys in all ten pairs of kidneys examined. In eight pairs IgM ap-
peared less in the experimental kidney. The overall impression was of slightly 
diminished HAR in the experimental group, although there was no statistical dif-
ference between experimental and control animals. 
Coagulation and Platelet Changes 
In both experimental and control animals, HAR was accompanied by a fall in the 
platelet count and a shortening of the plasma procoagulant activity (Table 4). 
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Table 4 
Coagulation and Platelet Changes 
Time after Transplant 
Parameter 15 min 45 min 90 min 
% Shortening of 11500 APTT 9 15 23 
p value NS .08 .001 
% Fall in platelet count 31 46 69 
p value NS .01 .001 
Electrolyte Changes During Immunodepletion 
Immunodepletion produced significant perturbations of specific electrolytes. A 
marked fall in ionized calcium was seen regularly, to the extent that each animal 
required infusion of 3-4 g of CaCl2 during each treatment. This effect may have 
been a result of citrate being used as an anticoagulant. Potassium replacement on 
the order of 60 mEq treatment was also required. 
Discussion 
The pig-to-dog renal xenotransplantation model reliably leads to a violent hyper-
acute rejection in 2-10 min. It is thus an extreme analogue of the hyperacute 
rejection seen in a renal transplant recipient sensitized to a given donor kidney. 
This rejection is thought to be antibody mediated. With the new technology of 
column employing immobilized protein A, immunodepletion of IgG and IgM can 
be used to decrease the antibody level and thus possibly decrease or eliminate the 
hyperacute rejection response. We have demonstrated a 65-90% reduction of 
antibody levels, with corresponding changes in preformed cytotoxic antibody 
titers. This reduction was associated with a modest decrease in the severity of 
HAR. Obviously, more progress will need to be made with this technology before 
effective abrogation of HAR can be expected. Research is continuing in our labo-
ratories to assess the efficacy of immunodepletion in combination with other im-
munosuppressive and pharmacologic protocols. If successful, the protein A 
column may be used in the future to immunodeplete the highly sensitized recip-
ient prior to transplantation. 
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